{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:57:51Z","timestamp":1785250671272,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00115-024-01705-6","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T13:02:07Z","timestamp":1724677327000},"page":"818-823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Die Herausforderungen f\u00fcr die psychiatrische Versorgung durch synthetische Drogen","The challenges for psychiatric care posed by synthetic drugs"],"prefix":"10.1007","volume":"95","author":[{"given":"Norbert","family":"Scherbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"1705_CR1","unstructured":"Abdulrahim D, on behalf of the NEPTUNE Expert Group (2015) Guidance on the Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances. Novel Psychoactive Treatment UK Network (NEPTUNE). London. https:\/\/ecom.ngo\/wp-content\/uploads\/2018\/01\/NEPTUNE-Guidance-March-2015.pdf"},{"key":"1705_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000501310","volume":"25","author":"F Betzler","year":"2019","unstructured":"Betzler\u00a0F, Ernst\u00a0F, Helbig\u00a0J, Viohl\u00a0L, Roediger\u00a0L, Meister\u00a0S, Romanczuk-Seifert\u00a0N, Heinz\u00a0A, Str\u00f6hle\u00a0A, K\u00f6hler\u00a0S (2019) Substance use and prevention programs in Berlin\u2019s party scene: Results of the SuPrA-study. Eur Addict Res 25:283\u2013292","journal-title":"Eur Addict Res"},{"key":"1705_CR3","unstructured":"BzgA (2020) Die Drogenaffinit\u00e4t Jugendlicher in der Bundesrepublik Deutschland 2019. https:\/\/www.bzga.de\/fileadmin\/user_upload\/PDF\/pressemitteilungen\/daten_und_fakten\/Info-Blatt_01._Juli_2020.pdf"},{"key":"1705_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3390\/ph14080720","volume":"14","author":"V Catalani","year":"2021","unstructured":"Catalani\u00a0V, Botha\u00a0M, Corkery\u00a0JM, Guirgis\u00a0A, Vento\u00a0A, Scherbaum\u00a0N, Schifano\u00a0F (2021) The psychonauts\u2019 benzodiazepines; quantitative structure-activity relationship (QSAR) analysis and docking prediction of their biological activity. Pharmaceuticals 14:720","journal-title":"Pharmaceuticals"},{"key":"1705_CR5","doi-asserted-by":"publisher","unstructured":"Davies B, Paul R, Osselton D (2023) Wastewater analysis for new psychoactive substances and cocaine and cannabis in a\u00a0Northern Ireland Prison. Sci Rep. Oct 30;13(1):18634. https:\/\/doi.org\/10.1038\/s41598-023-44453-4.","DOI":"10.1038\/s41598-023-44453-4"},{"issue":"1","key":"1705_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.drugalcdep.2019.107772","volume":"2020","author":"SB Dolan","year":"2020","unstructured":"Dolan\u00a0SB, Johnson\u00a0MW (2020) The drug purity discounting task: Ecstasy use likelihood is reduced by probabilistic impurity according to harmfulness of adulterants. Drug Alcohol Depend 2020(1):208\u2013107772. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107772","journal-title":"Drug Alcohol Depend"},{"key":"1705_CR7","unstructured":"EMCDDA\/Europol (2022) Europas sich wandelnde Rolle beim Ausbau der Kokain- und Methamphetamin-M\u00e4rkte. Pressemeldung am 6. Mai 2022. Highlights_EDMR2022_DE_cocaine_meth_FINALweb.pdf"},{"key":"1705_CR8","unstructured":"EMCDDA (2023) European Drug Report 2023: Trends and Developments. https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2023_en"},{"key":"1705_CR9","unstructured":"EMCDDA (2024) Synthetische Cannabinoide: Drogenprofil. https:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/synthetic-cannabinoids_de"},{"key":"1705_CR10","unstructured":"EMCDDA (2024) Synthetische Cathinone: Drogenprofil. https:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/synthetic-cathinones_de"},{"issue":"6","key":"1705_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s15005-020-1383-5","volume":"22","author":"M Gertzen","year":"2020","unstructured":"Gertzen\u00a0M, R\u00fcther\u00a0T (2020) Chemsex und sexualisierter Substanzgebrauch. Info Neurol Psychiatr 22(6):34\u201339","journal-title":"Info Neurol Psychiatr"},{"key":"1705_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/15563650.2017.1393082","volume":"56","author":"M Hermanns-Clausen","year":"2018","unstructured":"Hermanns-Clausen\u00a0M, M\u00fcller\u00a0D, Kithinji\u00a0J, Angerer\u00a0V, Franz\u00a0F, Eyer\u00a0F, Neurath\u00a0H, Liebetrau\u00a0G, Auw\u00e4rter\u00a0V (2018) Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA. Clin Toxicol 56:404\u2013411","journal-title":"Clin Toxicol"},{"key":"1705_CR13","unstructured":"Kraus L (2019) Abschlussbericht (Sachbericht) Projekttitel: Evaluation der Auswirkungen des Neue-psychoaktive-Stoffe-Gesetzes (NpSG). https:\/\/ift.de\/wp-content\/uploads\/2022\/08\/Kraus_et_al_2020_NpSG-Abschlussbericht.pdf"},{"issue":"4","key":"1705_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/YCO.0000000000000712","volume":"34","author":"RM Krausz","year":"2021","unstructured":"Krausz\u00a0RM, Westenberg\u00a0JN, Ziafat\u00a0K (2021) The opioid overdose crisis as a\u00a0global health challenge. Curr Opin Psychiatry 34(4):405\u2013412","journal-title":"Curr Opin Psychiatry"},{"key":"1705_CR15","doi-asserted-by":"publisher","unstructured":"Lemen PM, Garrett DP, Thompson E, Aho M, Vasquez C, Park JN (2023) High-Dose Naloxone Formulations Are Not as Essential as We Thought. medRxiv 2023 Aug 14:2023.08.07.23293781. https:\/\/doi.org\/10.1101\/2023.08.07.23293781.","DOI":"10.1101\/2023.08.07.23293781"},{"key":"1705_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/add.15734","volume":"117","author":"N Maghsoudi","year":"2021","unstructured":"Maghsoudi\u00a0N, Tanguay\u00a0J, Scarfone\u00a0K, Rammohan\u00a0I, Ziegler\u00a0C, Werb\u00a0D, Scheim\u00a0AI (2021) Drug checking services for people who use drugs: a\u00a0systematic review. Addiction 117:532\u2013544","journal-title":"Addiction"},{"issue":"10209","key":"1705_CR17","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/S0140-6736(19)32231-7","volume":"394","author":"A Peacock","year":"2019","unstructured":"Peacock\u00a0A, Bruno\u00a0R, Gisev\u00a0N, Degenhardt\u00a0L, Hall\u00a0W, Sedefov\u00a0R, White\u00a0J, Thomas\u00a0KV, Farrell\u00a0M, Griffiths\u00a0P (2019) New psychoactive substances: challenges for drug surveillance, control, and public health responses. Lancet 394(10209):1668\u20131684","journal-title":"Lancet"},{"key":"1705_CR18","volume-title":"Dein Crack ist in der Post","author":"M Power","year":"2014","unstructured":"Power\u00a0M (2014) Dein Crack ist in der Post. Eichborn, Frankfurt am Main"},{"issue":"119","key":"1705_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3238\/arztebl.m2022.0244","volume":"2022","author":"C Rauschert","year":"2022","unstructured":"Rauschert\u00a0C, M\u00f6ckl\u00a0J, Seitz\u00a0N\u2011N, Wilms\u00a0N, Olderbak\u00a0S, Kraus\u00a0L (2022) Konsum psychoaktiver Substanzen in Deutschland \u2013 Ergebnisse des Epidemiologischen Suchtsurvey 2021. Dtsch \u00c4rztebl Int 2022(119):527\u2013534. https:\/\/doi.org\/10.3238\/arztebl.m2022.0244","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"1705_CR20","volume-title":"Das Drogentaschenbuch","author":"N Scherbaum","year":"2024","unstructured":"Scherbaum\u00a0N (2024) Das Drogentaschenbuch, 7.\u00a0Aufl. Thieme, Stuttgart","edition":"7"},{"issue":"20","key":"1705_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pnpbp.2020.110144","volume":"2021","author":"N Scherbaum","year":"2021","unstructured":"Scherbaum\u00a0N, Seiffert\u00a0F, Schifano\u00a0F, Specka\u00a0M, Bonnet\u00a0U, Bender\u00a0S (2021) High lifetime, but low current, prevalence of new psychotropic substances (NPS) use in German drug detoxification treatment young inpatients. Prog Neuropsychopharmacol Biol Psychiatry 2021(20):111\u2013110144. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110144","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1705_CR22","volume-title":"PiHKal _ A Chemical Love Story","author":"A Shulgin","year":"1991","unstructured":"Shulgin\u00a0A, Shulgin\u00a0A (1991) PiHKal _ A Chemical Love Story. Transform Press, Berkeley"},{"key":"1705_CR23","volume-title":"TiHKAL \u2013 The Continuation","author":"A Shulgin","year":"1997","unstructured":"Shulgin\u00a0A, Shulgin\u00a0A (1997) TiHKAL \u2013 The Continuation. Transform Press, Berkeley"},{"key":"1705_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.coph.2021.02.008","volume":"57","author":"F Schifano","year":"2021","unstructured":"Schifano\u00a0F, Chiappini\u00a0S, Corkery\u00a0JM, Scherbaum\u00a0N, Guirguis\u00a0A (2021) The e\u2011psychonaut drugs\u2019 psychopharmacology. Curr Opin Pharmacol 57:165\u2013174","journal-title":"Curr Opin Pharmacol"},{"key":"1705_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/1751122433.2023.2279192","volume-title":"Stimulant and hallucinogenic novel psychoactive substances; a\u00a0review","author":"F Schifano","year":"2023","unstructured":"Schifano\u00a0F, Vento\u00a0A, Scherbaum\u00a0N, Guirgis\u00a0A (2023) Stimulant and hallucinogenic novel psychoactive substances; a\u00a0review. Expert, Review of Clinical Pharmacology https:\/\/doi.org\/10.1080\/1751122433.2023.2279192"},{"key":"1705_CR26","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s42256-021-00407-x","volume":"3","author":"MA Skinnider","year":"2021","unstructured":"Skinnider\u00a0MA, Wang\u00a0F, Pasin\u00a0D, Greiner\u00a0R, Foster\u00a0LJ, Dalsgaard\u00a0PW, Wishart\u00a0DSA (2021) Deep generative model enables automated structure elucidation of novel psychoactive substances. Nat Mach Intell 3:973\u2013984","journal-title":"Nat Mach Intell"},{"issue":"7","key":"1705_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fpsyt.2020.00569","volume":"2020","author":"M Specka","year":"2020","unstructured":"Specka\u00a0M, Kuhlmann\u00a0T, Sawazki\u00a0J, Bonnet\u00a0U, Steinert\u00a0R, Cybulska-Rycicki\u00a0M, Eich\u00a0H, Zeiske\u00a0B, Niedersteberg\u00a0A, Schaaf\u00a0L, Scherbaum\u00a0N (2020) Prevalence of Novel Psychoactive Substance (NPS) use in patients admitted to drug detoxification treatment. Front Psychiatry 2020(7):11\u2013569. https:\/\/doi.org\/10.3389\/fpsyt.2020.00569","journal-title":"Front Psychiatry"},{"key":"1705_CR28","unstructured":"Statista (2024) Entwicklung des Wirkstoffgehalts in Ecstasy-Tabletten in Deutschland in den. Jahren 1995: (bis 2019(MDMA-HCL in Milligramm) https:\/\/de.statista.com\/statistik\/daten\/studie\/1175090\/umfrage\/entwicklung-des-wirkstoffgehalts-in-ecstasy-tabletten-in-deutschland)"},{"key":"1705_CR29","doi-asserted-by":"publisher","unstructured":"Tanz LJ, Gladden RM, Dinwiddie AT, Miller KD, Broz D, Spector E, O\u2019Donnell J. (2024) Routes of Drug Use Among Drug Overdose Deaths - United States, 2020\u20132022. MMWR Morb Mortal Wkly Rep. 2024 Feb 15;73(6):124\u2013130. https:\/\/doi.org\/10.15585\/mmwr.mm7306a2. PMID: 38358969; PMCID: PMC10899081.","DOI":"10.15585\/mmwr.mm7306a2"},{"key":"1705_CR30","volume-title":"Fentanyl \u2013 Neue Drogenkartelle und die t\u00f6dliche Welle der Opioidkrise","author":"B Westhoff","year":"2021","unstructured":"Westhoff\u00a0B (2021) Fentanyl \u2013 Neue Drogenkartelle und die t\u00f6dliche Welle der Opioidkrise. Hirzel, Stuttgart"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01705-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-024-01705-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01705-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T13:04:09Z","timestamp":1725455049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-024-01705-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1705"],"URL":"https:\/\/doi.org\/10.1007\/s00115-024-01705-6","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"20 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"N.\u00a0Scherbaum und U.\u00a0Bonnet geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}